Hyperfine, Inc.

The health technology company develops and commercializes artificial intelligence-powered portable magnetic resonance imaging solutions. Its principal offering is the Swoop Portable MR Imaging System, an ultra-low-field brain scanner integrated with deep learning software designed to deliver neuroimaging directly at the point of care, including bedside hospital settings and outpatient clinics. Operating alongside the scanner hardware, the business provides proprietary software sequences, annual service agreements, and a subscription-based research data platform. The company primarily serves healthcare providers, including critical care units, emergency departments, inpatient hospital facilities, and office-based neurology practices, as well as international clinical providers.

Direct commercial activities occur primarily within the United States, complemented by authorized third-party distributor relationships that serve international healthcare institutions across Canada and select markets in Europe, Asia, Oceania, and the Middle East. Beyond the domestic market, regulatory marketing authorizations and product approvals span Canada, Australia, New Zealand, India, the United Kingdom, and the European Union.

Summary of the business section of Hyperfine's latest annual report, written by StockData.

“As of February 15, 2026, we had 102 employees, all of whom were full-time employees and of whom 24 work in sales, marketing, and commercial support, 56 work in research, development, clinical, technical assistance, supply chain, operations and logistics and 22 work in general and administrative capacities.”